MATWIN is an accelerator program aiming at challenging and maximizing innovation transfer potential exclusively on oncology. Through a support course 3 months, candidates will have access to support through expertise, coaching/mentoring and a qualified network of partners likely to help them accelerate the development of their project.
Restricted to startups with preclinical results of regulatory tox or a first clinical study (Phase 1) for therapeutic innovations or a validated test for diagnostic tests
Before submitting an application, please contact the MATWIN team in advance to jointly assess its relevance, depending on the objectives and stage of the project development. Depending on the geographical origin of the project, the discussion about the interest of a MATWIN application may be shared with the representatives of local partners (cancer cluster, incubator, technology transfer office, etc.)
contact@matwin.fr / +33 5 35 54 19 36
Application by January 31, 2026